NEWARK, Del, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The global erectile dysfunction device market is anticipated to reach a valuation of US$ 1.5 billion in 2024, driven by healthcare reimbursement policies. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 9.5% between 2024 and 2034, and reaching a total valuation of approximately US$ 3.9 billion by 2034.
One of the major factors contributing to the growth of the market is the integration of digital health technologies, including mobile applications, wearables, and sensor based devices, into erectile dysfunction treatment platforms, which enables remote monitoring of treatment progress, data analytics, and personalized intervention strategies, thereby enhancing patient outcomes and driving market growth.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18918
Increasing awareness initiatives focusing on male sexual health and wellness are driving conversations around erectile dysfunction, encouraging men to seek timely medical intervention and explore available treatment options, including erectile dysfunction devices.
Collaborative efforts between academia, industry stakeholders, and patient advocacy groups facilitate knowledge exchange, research collaboration, and the development of innovative erectile dysfunction devices tailored to address evolving patient needs and treatment paradigms.
The emergence of regenerative medicine therapies, such as platelet rich plasma therapy and stem cell-based treatments, offers potential alternatives or complementary approaches to conventional erectile dysfunction treatments, presenting new opportunities for market expansion and therapeutic innovation.
There is growing interest in non-pharmacological solutions, with concerns over the side effects and contraindications of pharmaceutical interventions for erectile dysfunction, which includes devices like penile traction therapy, which aims to address ED through mechanical means without relying on medication.
Incorporating AI and machine learning algorithms into ED devices and treatment platforms can enhance diagnostic accuracy, treatment planning, and outcome prediction. AI-enabled devices can analyze patient data, identify patterns, and optimize treatment protocols for improved efficacy and patient satisfaction.
“The proliferation of e-commerce platforms and direct-to-consumer sales channels enables erectile dysfunction device manufacturers to reach a broader audience and bypass traditional distribution networks. The trend enhances market accessibility and facilitates consumer education and product awareness,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Key Takeaways from the Market Study:
- The global erectile dysfunction device market was valued at US$ 1.4 billion in 2023.
- From 2019 to 2023, the market demand expanded at a CAGR of 11.7%.
- The market in Japan is expected to expand at a CAGR of 8.7% through 2034.
- By device type, the non-surgical devices segment accounts for a CAGR of 9.3% through 2034.
- The absolute dollar growth of the market is projected to reach a value of US$ 2.3 billion during the forecast period.
- The market in the United Kingdom is expected to expand at a CAGR of 10.2% through 2034.
Act Now to Explore In-Depth Market Analysis: Get an Exclusive Discount Now to Access Competitive Analysis: https://www.futuremarketinsights.com/checkout/18918
Competitive Landscape:
Prominent players in the erectile dysfunction device market are:
- Boston Scientific Corporation
- Coloplast Corp.
- Zephyr Surgical Implants
- Owen Mumford Ltd.
- Augusta Medical Systems
- Storz medical AG
- Promedon
- The Elator
- Timm Medical
- Silimed
- Giddy
- Alma Lasers
Recent Development:
- In 2022, Wikkon achieved the successful installation of the latest extracorporeal shock wave lithotripter, the HK ESWL 108A model, at Maria Clinic in Dili, East Timor.
Segmentation Analysis of the Erectile Dysfunction Device Market:
By Device Type:
- Non Surgical Devices
- Vaccum Construction Devices
- Erectile Dysfunction Shockwave Generators
- External Penile Rigidity Devices
- Surgical Devices
- Penile Implants
- Inflatable Implants
- Malleable Implants
By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Experience The Impact of Our Methodology Insights First hand: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-18918
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage in the Healthcare Market Insights Domain:
Age Related Vision Dysfunction Market Size: The global age-related vision dysfunction market garnered a market value of US$ 90 Billion in 2023 and is expected to accumulate a market value of US$ 130 Billion by registering a CAGR of 3.7% in the forecast period 2022 to 2033.
Pelvic Floor Stimulators Market Share: global sales of the pelvic floor stimulators industry are projected to total US$ 140.39 million for 2023. The demand outlook for the market remains buoyant as FMI forecasts it to exhibit a CAGR of 8.8% from 2023 to 2033, reaching US$ 325.41 million by 2033.
Spinal Devices Market Demand: The global spinal devices market is expected to grow at a CAGR of 5.3% during the period 2022-2032. The market is expected to hold a valuation of US$ 21.96 billion by 2032, and as on 2022, the market is valued at US$ 13.1 billion.
Molecular Diagnostics Market Trends: The global molecular diagnostics market is projected to have a moderate-paced CAGR of 18% during the forecast period. The current valuation of the market is US$ 14802.156 Million in 2022. The market value of the molecular diagnostics market is anticipated to reach a high of US$ 59882.97671 Million by the year 2032.
Molecular Cytogenetics Market Outlook: Global molecular cytogenetics market demand is anticipated to be valued at US$ 2,761.9 Million in 2022, forecast a CAGR of 8.9% to be valued at US$ 6,469.2 Million from 2022 to 2032.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
